Cardiovascular disease in dialysis patients

M Cozzolino, M Mangano, A Stucchi… - Nephrology Dialysis …, 2018 - academic.oup.com
Cardiovascular disease (CVD) is a highly common complication and the first cause of death
in patients with end-stage renal disease (ESRD) on haemodialysis (HD). In this population …

The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review

R Vanholder, E Schepers, A Pletinck… - Journal of the …, 2014 - journals.lww.com
A growing number of publications supports a biologic effect of the protein-bound uremic
retention solutes indoxyl sulfate and p-cresyl sulfate. However, the use of unrealistically high …

Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting

F Costa, D Van Klaveren, F Feres, S James… - Journal of the American …, 2019 - jacc.org
Background: Complex percutaneous coronary intervention (PCI) is associated with higher
ischemic risk, which can be mitigated by long-term dual antiplatelet therapy (DAPT) …

Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation

JR Liu, H Miao, DQ Deng, ND Vaziri, P Li… - Cellular and Molecular …, 2021 - Springer
The gut microbiota has a crucial effect on regulating the intestinal mucosal immunity and
maintaining intestinal homeostasis both in health and in disease state. Many effects are …

Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease

N Paeslack, M Mimmler, S Becker, Z Gao, MP Khuu… - Amino Acids, 2022 - Springer
The essential amino acid tryptophan (Trp) is metabolized by gut commensals, yielding in
compounds that affect innate immune cell functions directly, but also acting on the aryl …

The gut–kidney axis

P Evenepoel, R Poesen, B Meijers - Pediatric Nephrology, 2017 - Springer
The host–gut microbiota interaction has been the focus of increasing interest in recent years.
It has been determined that this complex interaction is not only essential to many aspects of …

Indoxyl sulfate—review of toxicity and therapeutic strategies

SC Leong, TL Sirich - Toxins, 2016 - mdpi.com
Indoxyl sulfate is an extensively studied uremic solute. It is a small molecule that is more
than 90% bound to plasma proteins. Indoxyl sulfate is derived from the breakdown of …

Implication of gut microbiota metabolites in cardiovascular and metabolic diseases

F Brial, A Le Lay, ME Dumas, D Gauguier - Cellular and molecular life …, 2018 - Springer
Evidence from the literature keeps highlighting the impact of mutualistic bacterial
communities of the gut microbiota on human health. The gut microbita is a complex …

Gut-derived protein-bound uremic toxins

AL Graboski, MR Redinbo - Toxins, 2020 - mdpi.com
Chronic kidney disease (CKD) afflicts more than 500 million people worldwide and is one of
the fastest growing global causes of mortality. When glomerular filtration rate begins to fall …

Uremic toxin indoxyl sulfate promotes proinflammatory macrophage activation via the interplay of OATP2B1 and Dll4-Notch signaling: Potential mechanism for …

T Nakano, S Katsuki, M Chen, JL Decano, A Halu… - Circulation, 2019 - Am Heart Assoc
Background: Chronic kidney disease (CKD) increases cardiovascular risk. Underlying
mechanisms, however, remain obscure. The uremic toxin indoxyl sulfate is an independent …